Search the Newsreel

Rico Auto Industries posts ₹3.38 crore consolidated loss in Q1FY26

CAPR INVESTOR ALERT: Capricor Therapeutics Securities Class Action Filed; September 28, 2026 Lead Plaintiff Deadline - Kehoe Law Firm

Kehoe Law Firm has filed a securities class action lawsuit against Capricor Therapeutics (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor made misleading statements by changing the statistical analysis plan …

Robbins LLP Urges CAPR Stockholders Who Lost Money Investing in Capricor Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is informing investors who lost money in Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025, and July 26, 2026, about a securities class action lawsuit. The lawsuit alleges Capricor misled investors regarding the FDA approval path for its lead product, Deramiocel, …

CAPR Investor Announcement: Capricor Therapeutics Sued on behalf of Investors to Recover Losses after Clinical Data Leads to 64% Stock Drop

Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (CAPR) for securities fraud. The lawsuit alleges that Capricor made false statements regarding its lead product candidate, Deramiocel, and the integrity of its clinical data, which led to a …

Americold Enables Direct-to-Consumer Growth Through Integrated Cold Chain Fulfillment Solutions

Americold Realty Trust A Media Snippet accompanying this announcement is available by clicking on this link. ATLANTA, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services, is enabling food producers and …

Americold Cold Chain Can Reach 99.5% of U.S. Population Within 2 Days

Americold (NYSE: COLD) has expanded its integrated e-commerce fulfillment solutions, enabling food producers to scale direct-to-consumer (DTC) and omnichannel models within its temperature-controlled network. The company reported shipping over one million DTC packages in the past year with double-digit growth, utilizing five U.S. sites …

Rico Auto Industries Q1 Results: Earnings call scheduled for Aug 14

Americold Realty Trust (COLD) Results Put Valuation Back In Focus After Impairment Charge

Americold Realty Trust Signals Turnaround in Earnings Call

Americold Realty Trust's latest earnings call conveyed a cautiously optimistic outlook, with management highlighting operational improvements and a clearer balance sheet strategy. The company reported outperforming expectations with a Q2 AFFO of $0.35 per share and raised its full-year AFFO guidance. Key drivers for …

Imricor Adds Children’s Medical Center Dallas as Second U.S. NorthStar Customer

Americold Realty Trust, Inc. (COLD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Americold Realty Trust, Inc. (COLD) following the company's disclosure of a $305 million to $320 million non-cash impairment charge. This charge is a result of terminating an agreement with ADUSA Distribution, LLC for operations …

Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 28, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor made unauthorized changes to its statistical analysis …

CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline

Hagens Berman has filed a securities fraud class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR), encouraging investors who suffered substantial losses to come forward. The lawsuit alleges that Capricor made false and misleading statements about its Duchenne muscular dystrophy drug, Deramiocel, particularly concerning …

Capricor to Host Rare-Disease Therapy Update Aug. 13

Capricor Therapeutics (NASDAQ: CAPR) announced it will release its second-quarter 2026 financial results after market close on Thursday, August 13, 2026, followed by a conference call and webcast at 4:30 p.m. ET. The company will discuss its financial performance and provide a corporate update, …

Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13

Capricor Therapeutics announced it will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results and provide a …

Capricor Therapeutics (NASDAQ:CAPR) Securities Class Action Notice: Investors who Lost Money when Stock Plummeted 64% are Notified to Contact BFA Law by September 28

Imricor Medical Systems Reports Q2 2026 Results with $60.5M Cash and $192.7M Accumulated Deficit

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has announced that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain of its officers, alleging violations of federal securities laws. The lawsuit seeks to recover damages for investors who purchased Capricor securities …

Stephens Upgrades TriCo Bancshares(TCBK.US) to Buy Rating

Stephens has upgraded TriCo Bancshares (TCBK.US) to a Buy rating. This indicates a positive outlook from the analyst firm regarding the company's stock performance.

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor made undisclosed changes to its statistical analysis …

Americold Realty Trust (COLD) Is Up 6.2% After Impairment-Driven Loss But Higher AFFO Outlook

In the past quarter, Americold Realty Trust, Inc. reported Q2 2026 revenue of US$662.89 million but swung from a small profit to a US$342.81 million net loss, largely driven by a very large US$309.57 million impairment of long-lived assets, while also filing an omnibus …

TRICO Bancshares 2Q 2026: Revenue $139.2M, EPS $1.06— 10-Q Summary

TRICO Bancshares reported strong second-quarter 2026 results, with revenue of $139.2 million and net income of $34.2 million. The company achieved diluted EPS of $1.06, driven by significant loan growth and reduced deposit funding costs. A definitive merger agreement with First Hawaiian was also …

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

ClaimsFiler is alerting investors of Capricor Therapeutics (CAPR) who suffered losses exceeding $100,000 about an upcoming lead plaintiff deadline in a class action lawsuit. The lawsuit alleges that Capricor and its executives failed to disclose material information regarding changes to the statistical analysis plan …

Americold Realty Earnings: Occupancy Improvements Lead to Better-Than-Expected Net Operating Income

Americold Realty reported adjusted funds from operations of $0.35 per share and a 1.5% decline in same-store net operating income for its warehouse segment in the second quarter. The article highlights that occupancy improvements contributed to better-than-expected net operating income. This report is part …

Americold Realty Trust, Inc. (COLD) Stock Forecasts

The article "Americold Realty Trust, Inc. (COLD) Stock Forecasts" is a placeholder or an article that failed to load properly on Yahoo Finance. It only contains navigation, advertisements, and error messages, indicating that the intended content about COLD stock forecasts is not available.

Imricor Medical Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kahn Swick & Foti, LLC (KSF) has announced a class action securities lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) for investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor and its executives failed to disclose material …

Tangible book value per share of Capricor Therapeutics, Inc. – HAM:4LN2

This article provides the tangible book value per share for Capricor Therapeutics, Inc. (HAM:4LN2). It notes that the market for this stock on the Hamburg Stock Exchange is currently closed with no trades. The information is presented within the context of TradingView's financial data …

Trico Bancshares (TCBK) Stock News Today

CREDIT AGRICOLE SA: Crédit Agricole S.A. launches a Share Repurchase Program for up to 32 million ordinary shares of the Company

CREDIT AGRICOLE SA Press release Montrouge, August 7th, 2026 Crédit Agricole S.A. launches a Share Repurchase Program for up to 32 million ordinary shares of the Company Crédit Agricole S.A., having received all necessary supervisory approvals, announces today that it will start a share …

Credit Agricole (CRARY) Upgraded to Buy: Here's Why

Credit Agricole SA (CRARY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. …

CREDIT AGRICOLE SA: Availability of the 2026 interim financial report

CREDIT AGRICOLE SA Press release Montrouge, August 7th, 2026 Availability of the 2026 interim financial report Crédit Agricole S.A. informs the public that the Amendment A02 to the 2025 Universal Registration Document has been filed with the French Financial Markets Authority (AMF) on August …

How Americold’s Q2 2026 Impairment-Driven Loss Will Impact Americold Realty Trust (COLD) Investors

Americold Realty Trust (COLD) reported a significant net loss of US$342.81 million in Q2 2026, primarily due to a US$309.57 million asset impairment, despite stable revenue. This impairment raises questions about previous asset valuations and returns on invested capital, influencing the investment narrative focused …

Americold Realty Trust Inc. $COLD Holdings Decreased by Sei Investments Co.

Sei Investments Co. reduced its stake in Americold Realty Trust Inc. by 61.1% in the first quarter, selling 478,703 shares. Despite this, Americold reported strong Q2 results, exceeding revenue and FFO estimates, and raised its fiscal 2026 EPS guidance. However, the company faces caution …

Should Value Investors Buy Credit Agricole (CRARY) Stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

State Street Corporation (NASDAQ: CAPR custodian) holds 5.9% of Capricor Therapeutics

State Street Corporation has filed a Schedule 13G, disclosing a beneficial ownership of 5.9% of Capricor Therapeutics Inc. common stock, totaling 3,397,241 shares. The filing indicates that State Street holds 3,285,634 shares with shared voting power and 3,397,241 shares with shared dispositive power, primarily …